Xanomeline and Trospium Chloride for the Treatment of Agitation Associated With Schizophrenia
The Journal of Clinical Psychiatry · 24.03.2025 · 86 (2)
DOI: 10.4088/jcp.24m15668 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Psychiatry, online erschienen am 24.03.2025. Verfasst von Paul P Yeung und 4 weiteren Autor:innen. Beteiligte Einrichtung: Bristol Myers Squibb, Princeton, New Jersey. Hauptthemen laut MEDLINE: Schizophrenia, Nortropanes, Benzilates, Psychomotor Agitation. Die Arbeit wurde bisher 8-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Bristol Myers Squibb, Princeton, New Jersey.
- Corresponding Author: Paul P. Yeung, MD, MPH, Bristol Myers Squibb, 3401 Princeton Pike, Lawrenceville, NJ 08648 (paul.yeung@bms.com).
- Psychiatry Department, Indiana University School of Medicine, Indianapolis, Indiana.
Zitieren
APA
Yeung, P. P., Breier, A., Zhu, H., Kaul, I., & Marcus, R. N. (2025). Xanomeline and Trospium Chloride for the Treatment of Agitation Associated With Schizophrenia. The Journal of Clinical Psychiatry, 86(2). https://doi.org/10.4088/jcp.24m15668
Vancouver
Yeung PP, Breier A, Zhu H, Kaul I, Marcus RN. Xanomeline and Trospium Chloride for the Treatment of Agitation Associated With Schizophrenia. The Journal of Clinical Psychiatry. 2025;86(2). doi:10.4088/jcp.24m15668
BibTeX
@article{Yeung2025,
author = {Yeung, Paul P and Breier, Alan and Zhu, Haiyuan and Kaul, Inder and Marcus, Ronald N},
title = {Xanomeline and Trospium Chloride for the Treatment of Agitation Associated With Schizophrenia},
journal = {The Journal of Clinical Psychiatry},
year = {2025},
volume = {86},
number = {2},
doi = {10.4088/jcp.24m15668}
}
EUVIMED